• Liao, Y., et al. (2023). "Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression." Cell Death Dis 14(1): 66.
  • Liang, X., et al. (2023). "Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance following Infarction via Immune Modulation." Stem Cells Int 2023: 6256115.
  • Li, Y., et al. (2023). "Human umbilical cord-derived mesenchymal stem cell transplantation supplemented with curcumin improves the outcomes of ischemic stroke via AKT/GSK-3beta/beta-TrCP/Nrf2 axis." J Neuroinflammation 20(1): 49.
  • Chen, C., et al. (2023). "Alteration of Transcriptomic Profile and Antiseptic Efficacy of Adipose-Derived Mesenchymal Stromal/Stem Cells Under Different Culture Conditions." Stem Cells Dev 32(3-4): 75-86.
  • Yao, Y., et al. (2022). "PPARγ-dependent hepatic macrophage switching for hUCMSCs-mediated alleviation of decompensated liver cirrhosis in rats."
  • Xue, J., et al. (2022). "Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes." Stem Cell Res Ther 13(1): 109.
  • Lapuente, J. P., et al. (2022). "Evaluation in a Cytokine Storm Model In Vivo of the Safety and Efficacy of Intravenous Administration of PRS CK STORM (Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells)." Biomedicines 10(5).
  • Chen, C. H., et al. (2022). "Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO(2)/FiO(2) in severe COVID-19 pneumonia." Front Med (Lausanne) 9: 1001979.
  • Yao, Y., et al. (2021). "Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells." Stem Cell Res Ther 12(1): 294.
  • Lo, H. Y., et al. (2021). "High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDS." Cell Transplant 30: 9636897211054481.
  • Lo, H.-Y., et al. (2021). "The hUCMSCs Exerts Excellent Anti-inammation Effect which is Different from TCZ IL-6 Antagonist by Inducing High IL-6 Secretion."
  • Liao, G., et al. (2021). "Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia." Front Cell Dev Biol 9: 722953.
  • Chang, Y.-L., et al. (2021). "The potential of a single injection of hUCMSCs in relevant testis injury and severity of DSS induced acute and chronic colitis."
  • Chang, Y. L., et al. (2019). "Therapeutic effects of a single injection of human umbilical mesenchymal stem cells on acute and chronic colitis in mice." Sci Rep 9(1): 5832.
  • Chang, Y.-L., et al. (2019). "Therapeutic Efficacy of Subcutaneous and Intraperitoneal Injections of a Single Dose of Human Umbilical Mesenchymal Stem Cells in Acute and Chronic Colitis in a Mouse Model." Journal of Medical and Biological Engineering 40(1): 82-90.
  • Fan-Yen Lee, K.-H. C., Christopher Glenn Wallace, Pei-Hsun, et al. (2017). "Xenogeneic hUCMSCs reduce mortality in rats with acute respiratory distress by sepsis." Oncotarget.
  • 1